To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Despite the prevalence of cancer misinformation, exposure to it is not associated with greater fear of cancer recurrence or ...

Cardiovascular (CV) disease is a leading cause of death among patients with prostate cancer. | Cardiovascular (CV) disease is ...

ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...

MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...

Instead, he chose to be the first person in Texas to try Inlexzo. Inlexzo is a chemotherapy that comes in a tube that looks like pretzel. The tube straightens while it is inserted by catheter into the ...

Accordingly, it is not surprising that a leading institution such as Johns Hopkins Medicine is at the forefront of this trend. John Hopkins University was an early participant in the clinical ...

Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.

The Centres for Disease Control and Prevention in the United States notes that frequent urination "often at night" serves as ...